Clinical Trial Update: Fish Oil (Omega 3 ) in Sjogren's Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating fish oil (omega-3) in Sjogren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Fish Oil (Omega-3) (omega-3 fatty acids)

Snippet

Sponsor: Hawler Medical University | Conditions: Sjogren's Syndrome | Phase 2, Phase 3 | Status: COMPLETED